0001802806-22-000008.txt : 20220824 0001802806-22-000008.hdr.sgml : 20220824 20220824160329 ACCESSION NUMBER: 0001802806-22-000008 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20220824 DATE AS OF CHANGE: 20220824 EFFECTIVENESS DATE: 20220824 FILER: COMPANY DATA: COMPANY CONFORMED NAME: GELESIS HOLDINGS, INC. CENTRAL INDEX KEY: 0001805087 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 844730610 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-456915 FILM NUMBER: 221191547 BUSINESS ADDRESS: STREET 1: 501 BOYLSTON STREET, SUITE 6102 CITY: BOSTON STATE: MA ZIP: 02116 BUSINESS PHONE: 857-327-7737 MAIL ADDRESS: STREET 1: 501 BOYLSTON STREET, SUITE 6102 CITY: BOSTON STATE: MA ZIP: 02116 FORMER COMPANY: FORMER CONFORMED NAME: CAPSTAR SPECIAL PURPOSE ACQUISITION CORP. DATE OF NAME CHANGE: 20200227 D 1 primary_doc.xml X0708 D LIVE 0001805087 GELESIS HOLDINGS, INC. 501 BOYLSTON STREET, SUITE 6102 BOSTON MA MASSACHUSETTS 02116 617-456-4718 DELAWARE CAPSTAR SPECIAL PURPOSE ACQUISITION CORP. Corporation true 2020 Yishai Zohar GELESIS HOLDINGS, INC. 501 BOYLSTON STREET, SUITE 6102 BOSTON MA MASSACHUSETTS 02116 Executive Officer Director David Pass GELESIS HOLDINGS, INC. 501 BOYLSTON STREET, SUITE 6102 BOSTON MA MASSACHUSETTS 02116 Executive Officer Harry L. Leider GELESIS HOLDINGS, INC. 501 BOYLSTON STREET, SUITE 6102 BOSTON MA MASSACHUSETTS 02116 Executive Officer Elaine Chiquette GELESIS HOLDINGS, INC. 501 BOYLSTON STREET, SUITE 6102 BOSTON MA MASSACHUSETTS 02116 Executive Officer Alessandro Sannino GELESIS HOLDINGS, INC. 501 BOYLSTON STREET, SUITE 6102 BOSTON MA MASSACHUSETTS 02116 Executive Officer Elliot Maltz GELESIS HOLDINGS, INC. 501 BOYLSTON STREET, SUITE 6102 BOSTON MA MASSACHUSETTS 02116 Executive Officer David Abraham GELESIS HOLDINGS, INC. 501 BOYLSTON STREET, SUITE 6102 BOSTON MA MASSACHUSETTS 02116 Executive Officer Paul Fonteyne GELESIS HOLDINGS, INC. 501 BOYLSTON STREET, SUITE 6102 BOSTON MA MASSACHUSETTS 02116 Director Raju Kucherlapati GELESIS HOLDINGS, INC. 501 BOYLSTON STREET, SUITE 6102 BOSTON MA MASSACHUSETTS 02116 Director Jane Wildman GELESIS HOLDINGS, INC. 501 BOYLSTON STREET, SUITE 6102 BOSTON MA MASSACHUSETTS 02116 Director Dominic Perks GELESIS HOLDINGS, INC. 501 BOYLSTON STREET, SUITE 6102 BOSTON MA MASSACHUSETTS 02116 Director Alison Bauerlein GELESIS HOLDINGS, INC. 501 BOYLSTON STREET, SUITE 6102 BOSTON MA MASSACHUSETTS 02116 Director Clayton Christopher GELESIS HOLDINGS, INC. 501 BOYLSTON STREET, SUITE 6102 BOSTON MA MASSACHUSETTS 02116 Director Kathryn Cavanaugh GELESIS HOLDINGS, INC. 501 BOYLSTON STREET, SUITE 6102 BOSTON MA MASSACHUSETTS 02116 Director Pharmaceuticals Decline to Disclose 06b false 2022-08-11 true true false 0 50575684 575684 50000000 Total Offering Amount represents the aggregate of (i) up to $50,000,000 of common stock and (ii) 355,361 shares of common stock issued as consideration for entering into the Purchase Agreement. See the Issuer's Current Report on Form 8-K filed on 8/12/22. false 1 0 0 0 false GELESIS HOLDINGS, INC. /s/ Elliot Maltz Elliot Maltz Chief Financial Officer and Treasurer 2022-08-24